HTG Molecular Diagnostics
HTGM
$0.48
Share price
0.00%
Change (1 day)
-96.26%
Change (1 year)
Categories
Operating Margin for HTG Molecular Diagnostics (HTGM)
Operating Margin as of May 2024 (TTM): -326.08%
According to HTG Molecular Diagnostics 's latest financial reports and stock price the company's current Operating Margin is -326.08%. At the end of 2021 the company had an Operating Margin of -192.24%.
Operating Margin history for HTG Molecular Diagnostics from 2014 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -192.24% | -21.2% |
| 2020 | -243.96% | 142.82% |
| 2019 | -100.47% | 31.33% |
| 2018 | -76.50% | -40.44% |
| 2017 | -128.44% | -74.67% |
| 2016 | -507.13% | -4.17% |
| 2015 | -529.19% | 26.21% |
| 2014 | -419.30% | -20.09% |
| 2013 | -524.70% | 1.9% |
| 2012 | -514.91% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Lexicon Pharmaceuticals
LXRX | -87,620.60% | 26,770.89% | 🇺🇸 USA |
 Affimed
AFMD | -210.66% | -35.40% | 🇩🇪 Germany |
 Calithera Biosciences
CALA | -1,180.38% | 261.99% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.